Submitted by Anonymous (not verified) on 10 April 2026 - 10:34
Orphan designation: pegtarazimod Treatment of graft-versus-host disease, 22/08/2025 Positive
Source:
Orphan designation: pegtarazimod Treatment of graft-versus-host disease, 22/08/2025 Positive